Condition
Solid Tumors, Adult clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Solid Tumors, Adult clinical trials that are recruiting, at sites in 10 countries (most in China (7), United States (6), Belgium (1)). By phase: Phase 1 (5), Phase 1/2 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 10Countries
Newest Solid Tumors, Adult clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ABSK141 for advanced solid tumors with KRAS G12D mutation | Phase 1/2 | Shanghai | Recruiting | Feb 18, 2026 |
| HMPL-A580 for adults with advanced or metastatic solid tumors | Phase 1/2 | Orange, California and 13 other locations | Recruiting | Feb 9, 2026 |
| GC203 TIL therapy for advanced solid tumors in adults | Phase 1 | Shenzhen | Recruiting | Dec 1, 2025 |
| HMPL-A251 for adults with advanced or metastatic HER2-expressing solid tumors | Phase 1/2 | Denver, Colorado and 14 other locations | Recruiting | Nov 14, 2025 |
| PANK-003 cell injection with chemotherapy for solid tumors | Phase 1 | Anyang, Henan | Recruiting | Mar 26, 2025 |
| Evaluating DCR-PDL1 for adults with solid tumors | Phase 1 | Irving, Texas and 1 other locations | Recruiting | Jul 16, 2024 |
| Using low-dose chemotherapy with controlled blood sugar to treat advanced solid tumors | — | Wuxi, Jiangsu | Recruiting | May 8, 2024 |
| Investigating a new treatment for advanced solid tumors with HER-2 expression | Phase 1 | Dallas, Texas and 1 other locations | Recruiting | May 17, 2023 |
| Testing STX-478 for advanced solid tumors and breast cancer | Phase 1/2 | Los Angeles, California and 64 other locations | Recruiting | Mar 14, 2023 |
| Imaging solid tumors with a new radiolabeled agent | Phase 1 | San Francisco, California | Recruiting | Nov 9, 2020 |
All recruiting trials (10)
-
ABSK141 for advanced solid tumors with KRAS G12D mutation
This trial tests an oral drug called ABSK141 to see if it is safe and helps adults with advanced solid tumors that have a KRAS G12D mutation.
-
HMPL-A580 for adults with advanced or metastatic solid tumors
This tests whether HMPL-A580 is safe and might help adults with unresectable advanced or metastatic solid tumors.
-
GC203 TIL therapy for advanced solid tumors in adults
This trial tests GC203 tumor-infiltrating lymphocyte therapy in adults with solid tumors that have not responded to standard treatments.
-
HMPL-A251 for adults with advanced or metastatic HER2-expressing solid tumors
This trial will test a new drug called HMPL-A251 to see if it is safe and helps adults with unresectable or metastatic HER2-expressing solid tumors.
-
PANK-003 cell injection with chemotherapy for solid tumors
This study is testing if PANK-003 cell injections combined with chemotherapy can help people who have had surgery for solid tumors like lung or breast cancer feel better and improve their chances of recovery.
-
Evaluating DCR-PDL1 for adults with solid tumors
This study is testing a new treatment called DCR-PDL1 given through an IV to see if it's safe and works for adults with solid tumors.
-
Using low-dose chemotherapy with controlled blood sugar to treat advanced solid tumors
This study is testing if giving low-dose chemotherapy while keeping blood sugar levels low can help patients with advanced solid tumors that haven't responded to other treatments.
-
Investigating a new treatment for advanced solid tumors with HER-2 expression
This study is testing a new treatment called HF158K1 for people with advanced solid tumors that have HER-2 expression to see if it can work better than the treatments they’ve already tried.
-
Testing STX-478 for advanced solid tumors and breast cancer
This study is testing a new cancer drug called STX-478 to see if it can help people with advanced solid tumors and breast cancer, both on its own and when used with other treatments.
-
Imaging solid tumors with a new radiolabeled agent
This study is testing a new imaging agent to see if it can better detect metastatic cancer in patients with solid tumors compared to standard imaging methods.
Related topics
Quick answers
How many Solid Tumors, Adult clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in China (7 trials), United States (6 trials), Belgium (1 trial), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 5, Phase 1/2: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.